Literature DB >> 18622752

Engineering and assaying of cytochrome P450 biocatalysts.

Kersten S Rabe1, Valérie J Gandubert, Mark Spengler, Michael Erkelenz, Christof M Niemeyer.   

Abstract

Cytochrome P450s constitute a highly fascinating superfamily of enzymes which catalyze a broad range of reactions. They are essential for drug metabolism and promise industrial applications in biotechnology and biosensing. The constant search for cytochrome P450 enzymes with enhanced catalytic performances has generated a large body of research. This review will concentrate on two key aspects related to the identification and improvement of cytochrome P450 biocatalysts, namely the engineering and assaying of these enzymes. To this end, recent advances in cytochrome P450 development are reported and commonly used screening methods are surveyed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622752     DOI: 10.1007/s00216-008-2248-9

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  4 in total

1.  Rational engineering of the fungal P450 monooxygenase CYP5136A3 to improve its oxidizing activity toward polycyclic aromatic hydrocarbons.

Authors:  Khajamohiddin Syed; Aleksey Porollo; David Miller; Jagjit S Yadav
Journal:  Protein Eng Des Sel       Date:  2013-07-31       Impact factor: 1.650

Review 2.  Cytochrome P450: taming a wild type enzyme.

Authors:  Sang Taek Jung; Ryan Lauchli; Frances H Arnold
Journal:  Curr Opin Biotechnol       Date:  2011-03-14       Impact factor: 9.740

3.  Non-natural olefin cyclopropanation catalyzed by diverse cytochrome P450s and other hemoproteins.

Authors:  Thomas Heel; John A McIntosh; Sheel C Dodani; Joseph T Meyerowitz; Frances H Arnold
Journal:  Chembiochem       Date:  2014-10-07       Impact factor: 3.164

4.  An integrated screening system for the selection of exemplary substrates for natural and engineered cytochrome P450s.

Authors:  Naoki Kanoh; Ayano Kawamata-Asano; Kana Suzuki; Yusuke Takahashi; Takeshi Miyazawa; Takemichi Nakamura; Takashi Moriya; Hiroyuki Hirano; Hiroyuki Osada; Yoshiharu Iwabuchi; Shunji Takahashi
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.